Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Acta Neuropathol Commun ; 6(1): 116, 2018 10 31.
Artigo em Inglês | MEDLINE | ID: mdl-30382921

RESUMO

Pompe disease, which is due to acid alpha-glucosidase deficiency, is characterized by skeletal muscle dysfunction attributed to the accumulation of glycogen-filled lysosomes and autophagic buildup. Despite the extensive tissue damages, a failure of satellite cell (SC) activation and lack of muscle regeneration have been reported in patients. However, the origin of this defective program is unknown. Additionally, whether these deficits occur gradually over the disease course is unclear. Using a longitudinal pathophysiological study of two muscles in a Pompe mouse model, here, we report that the enzymatic defect results in a premature saturating glycogen overload and a high number of enlarged lysosomes. The muscles gradually display profound remodeling as the number of autophagic vesicles, centronucleated fibers, and split fibers increases and larger fibers are lost. Only a few regenerated fibers were observed regardless of age, although the SC pool was preserved. Except for the early age, during which higher numbers of activated SCs and myoblasts were observed, no myogenic commitment was observed in response to the damage. Following in vivo injury, we established that muscle retains regenerative potential, demonstrating that the failure of SC participation in repair is related to an activation signal defect. Altogether, our findings provide new insight into the pathophysiology of Pompe disease and highlight that the activation signal defect of SCs compromises muscle repair, which could be related to the abnormal energetic supply following autophagic flux impairment.


Assuntos
Doença de Depósito de Glicogênio Tipo II/patologia , Músculo Esquelético/fisiopatologia , Regeneração/fisiologia , Células Satélites de Músculo Esquelético/fisiologia , Fatores Etários , Animais , Autofagia/genética , Cardiotoxinas/toxicidade , Colágeno/metabolismo , Modelos Animais de Doenças , Distrofina/metabolismo , Regulação da Expressão Gênica/genética , Glucana 1,4-alfa-Glucosidase/deficiência , Glucana 1,4-alfa-Glucosidase/genética , Glicogênio/metabolismo , Doença de Depósito de Glicogênio Tipo II/etiologia , Humanos , Antígeno Ki-67/metabolismo , Laminina/metabolismo , Estudos Longitudinais , Lisossomos/metabolismo , Lisossomos/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Proteínas Associadas aos Microtúbulos/metabolismo , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/lesões , Regeneração/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA